Omnicell Inc

The stock is in a constructive Stage 2 advance with a clear series of higher highs and higher lows supported by rising EMAs and strong volume. Medium-term bias remains bullish, but short-term price is extremely overbought and extended above EMAs. Await a healthy pullback into rising EMAs for optimal entry.

• ↑15% YoY revenue growth to $310M in Q1 2026, beating guidance
• ↑Titan XT platform targets a $2.5B system refresh market
• ↓Tariffs forecast to cut non-GAAP EBITDA by ~$40M in 2025